Skip to main content

Table 3 Correlations of MGMT, RARβ, RASSF1A, and CDH13 promoter methylation with inflammatory and angiogenic factors.

From: High Incidence of MGMT and RARβ Promoter Methylation in Primary Glioblastomas: Association with Histopathological Characteristics, Inflammatory Mediators and Clinical Outcome

 

MGMT methylation

RARβ methylation

RASSF1A methylation

CDH13 methylation

 

Presence median (range)

Absence median (range)

P

Presence median (range)

Absence median (range)

P

Presence median (range)

Absence median (range)

P

Presence median (range)

Absence median (range)

P

IL-6 expression, %

64.5 (7–80)

15 (0–30)

0.004

69.5 (25–80)

15 (0–40)

0.002

75 (60–80)

25 (0–80)

0.0081

55 (25–80)

30 (0–80)

0.1320

IL-8 expression, %

17.5 (5–70)

10 (2–30)

0.2892

25 (10–70)

10 (2–30)

0.2326

17.5 (5–40)

15 (2–70)

0.2326

25 (5–70)

30 (2–30)

0.1640

VEGF expression, %

60 (50–80)

50 (40–70)

0.0679

65 (50–80)

60 (40–70)

0.0757

65 (5–80)

60 (40–70)

0.8034

65 (5–80)

60 (40–70)

0.8040

COX-2 expression, %

30 (10–70)

25 (15–40)

0.6603

37.5 (10–70)

25 (15–40)

0.1640

37.5 (10–70)

25 (15–40)

0.2821

37.5(10–70)

25 (15–40)

0.2821